Skip to main content
AAN.com
Articles
July 18, 2007
Letter to the Editor

Hospital volume and stroke outcome
Does it matter?

September 11, 2007 issue
69 (11) 1142-1151

Abstract

Background: Although hospital–outcome relationships have been explored for a variety of procedures and interventions, little is known about the association between annual stroke admission volumes and stroke mortality. Our aim was to determine whether facility type and hospital volume was associated with stroke mortality.
Methods: All hospital admissions for ischemic stroke were identified from the Hospital Morbidity database (HMDB) from April 2003 to March 2004. The HMDB is a national database that contains patient-level sociodemographic, diagnostic, procedural, and administrative information across Canada. Ischemic stroke was identified through patient's principal diagnosis recorded using the International Classification of Diseases (9 and 10). Multivariable analysis was performed with generalized estimating equations with adjustment for demographic characteristics, provider specialty, facility type, hospital volume, and clustering of observations at institutions.
Results: Overall, 26,676 patients with ischemic stroke were admitted to 606 hospitals. Seven-day stroke mortality was 7.6% and mortality at discharge was 15.6%. Adverse outcomes were more frequent in patients treated in low-volume facilities (<50 strokes/year) than in those treated in high volume facilities (100 to 199 and >200 strokes patients/year) (for 7-day mortality: 9.5 vs 7.3%, p < 0.001; 9.5 vs 6.0%, p < 0.001; for discharge mortality: 18.2 vs 15.2%, p < 0.001; 18.2 vs 12.8%, p < 0.001). The difference persisted after multivariable adjustment or when hospital volume was divided into quartiles.
Conclusions: High annual hospital volume was consistently associated with lower stroke mortality. Our study encourages further research to determine whether this is due to differences in case mix, more organized care in high-volume facilities, or differences in the performance or in the processes of care among facilities.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002;137:511–520.
2.
Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991–1994.
3.
Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43–53.
4.
Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998;29:1602–1604.
5.
Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005;36:1776–1781.
6.
AHRQ quality indicators—Guide to inpatient quality indicators: Quality of care in hospitals—Volume, mortality, and utilization. Rockville, MD: Agency for Healthcare Research and Quality, 2002. Revision 4 (December 22, 2004). AHRQ Pub. No. 02-RO204.
7.
Lynelle Moon PM. Stéphane Jacobzone and the ARD-Stroke Experts Group. Stroke Care in OECD countries: a comparison of treatment, Costs and outcomes in 17 countries. Paris: Organisation for Economic Co-operation and Development; June 6, 2003.
8.
Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke: a prospective review. Stroke 1984;15:492–496.
9.
Saposnik G, Webster F, O'Callaghan C, Hachinski V. Optimizing discharge planning: clinical predictors of longer stay after recombinant tissue plasminogen activator for acute stroke. Stroke 2005;36:147–150.
10.
Detsky AS, Naylor CD. Canada's health care system—reform delayed. N Engl J Med 2003;349:804–810.
11.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
12.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
13.
Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index co-morbidity adjustment for ischemic stroke outcome studies. Stroke 2004;35:1941–1945.
14.
Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med 2001;345:663–668.
15.
Wilkins R. Automated geographic coding based on the Statistics Canada postal code conversion files. Ottawa: Statistics Canada, 2004. Catalogue 82F0086-XDB.
16.
Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004;164:1761–1768.
17.
Luft HS. The relation between surgical volume and mortality: an exploration of causal factors and alternative models. Med Care 1980;18:940–959.
18.
Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003;157:364–375.
19.
Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP. Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 2003;34:2200–2207.
20.
Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964–974.
21.
Panageas KS, Schrag D, Riedel E, Bach PB, Begg CB. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med 2003;139:658–665.
22.
Data quality of the discharge abstract database following the first-year implementation of ICD-10-CA/CCI. Final report. Canadian Institute for Health Information. September 2004.
23.
Williams JI YW. Inventory of studies on the accuracy of Canadian health administrative databases. Toronto, Ontario, 1996. 96-03-TR.
24.
Williams JI YW. A summary of studies on the quality of health care administrative databases in Canada. 2nd ed. Ottawa: Institute of Clinical Effectiveness Sciences, 1996:339–3345.
25.
Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1106–1113.
26.
Bateman BT, Schumacher HC, Boden-Albala B, et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke 2006;37:440–446.
27.
Hannan EL, Popp AJ, Tranmer B, Fuestel P, Waldman J, Shah D. Relationship between provider volume and mortality for carotid endarterectomies in New York state. Stroke 1998;29:2292–2297.
28.
Hannan EL, Magaziner J, Wang JJ, et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA 2001;285:2736–2742.
29.
Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med 1979;301:1364–1369.
30.
Ellison LM, Heaney JA, Birkmeyer JD. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 2000;163:867–869.
31.
Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280:1747–1751.
32.
Freixinet JL, Julia-Serda G, Rodriguez PM, et al. Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases. Eur J Cardiothorac Surg 2006;29:20–25.
33.
Zimmerman J, Siguencia J, Tsvang E, Beeri R, Arnon R. Predictors of mortality in patients admitted to hospital for acute upper gastrointestinal hemorrhage. Scand J Gastroenterol 1995;30:327–331.
34.
Clague JE, Craddock E, Andrew G, Horan MA, Pendleton N. Predictors of outcome following hip fracture. Admission time predicts length of stay and in-hospital mortality. Injury 2002;33:1–6.
35.
Solomon RA, Mayer SA, Tarmey JJ. Relationship between the volume of craniotomies for cerebral aneurysm performed at New York state hospitals and in-hospital mortality. Stroke 1996;27:13–17.
36.
Kapral MK, Wang H, Austin PC, et al. Sex differences in carotid endarterectomy outcomes: results from the Ontario Carotid Endarterectomy Registry. Stroke 2003;34:1120–1125.
37.
Flood AB, Scott WR, Ewy W. Does practice make perfect? Part I: the relation between hospital volume and outcomes for selected diagnostic categories. Med Care 1984;22:98–114.
38.
Canadian Best Practice Recommendations for Stroke Care. Ottawa: Canadian Stroke Network and Heart Stroke Foundation Canada, 2006.
39.
Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916–923.
40.
Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597–1616.
41.
Yoneda Y, Uehara T, Yamasaki H, Kita Y, Tabuchi M, Mori E. Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 2003;34:718–724.
42.
Wong KS. Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: A prospective hospital-based study in Asia. Asian Acute Stroke Advisory Panel. Stroke 1999;30:2326–2330.
43.
Baptista MV, van Melle G, Bogousslavsky J. Prediction of in-hospital mortality after first-ever stroke: the Lausanne Stroke Registry. J Neurol Sci 1999;166:107–114.
44.
Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832–1840.
45.
Saposnik G, Baibergenova A, Bayer N, Hachinski V. Weekend: a dangerous time for having a stroke? Stroke 2007;38:1211–1215.
46.
Gillum LA, Johnston SC. Characteristics of academic medical centers and ischemic stroke outcomes. Stroke 2001;32:2137–2142.
47.
Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005;36:62–65.
48.
Hogue CW Jr, Barzilai B, Pieper KS, et al. Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report. Circulation 2001;103:2133–2137.
49.
Kapral MK, Fang J, Hill MD, et al. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005;36:809–814.
Letters to the Editor
12 October 2007
Hospital volume and stroke outcome: Does it matter?
James M Gordon, Northwest Hospital

Saposnik et al provide strong evidence that hospital volume generally predicts in-hospital mortality. [1] This begs the question whether in-hospital mortality is the best—or even a good— measure of stroke outcome. Did volume influence functional outcome or mortality at 3, 6, and 12 months?

Reference

1. Saposnik G, Baibergenova A, O'Donnell M, Hill MD, Kapral MK, V. Hachinski On behalf of the Stroke Outcome Research Canada (SORCan) Working Group. Hospital volume and stroke outcome. Neurology 2007; 0: 01.wnl.0000268485.93349.58v1

Disclosure: The author reports no conflicts of interest.

12 October 2007
Reply from the authors
Gustavo Saposnik, Assistant Professor in Medicine (Neurology)

We appreciate Dr. Gordon's interest and comments regarding our recently published article. [1] Unfortunately, we have no information about functional or long-term outcomes. We are currently working to further analyze the impact of organized care on stroke outcomes at 7 days, 30 days and 1 year.

Disclosure: Dr. Gustavo Saposnik received supprt from Heart Stroke Foundation Canada, the Canadian Institute for Health Research, Connaught Foundation, and Department of Research at St. Michael Hospital. Dr. Martin O'Donnell is supported by a grant from the CIHR. Dr. Moira Kapral is supported by a New Investigator Award from the CIHR and also received support from the Canadian Stroke Network and the University Health Network Women's Health Program. Dr. Michael Hill is supported by the Heart and Stroke Foundation of Alberta/NWT/NU and the Canadian Institutes for Health Research. These grants were obtained based on competitive applications following publication of grant advertisements. The investigators acted as the sponsors of the study. None of the supporting agencies (HSFC, CSN, CIHR) had input on the design, access to the data, analyses, interpretation, or publication of the study.

Information & Authors

Information

Published In

Neurology®
Volume 69Number 11September 11, 2007
Pages: 1142-1151
PubMed: 17634420

Publication History

Published online: July 18, 2007
Published in print: September 11, 2007

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

G. Saposnik, MD, MSc
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.
A. Baibergenova, MD, PhD
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.
M. O'Donnell, MD
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.
M. D. Hill, MD, MSc
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.
M. K. Kapral, MD, MSc
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.
V. Hachinski, MD, DSc
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.
On behalf of the Stroke Outcome Research Canada (SORCan) Working Group
From the Stroke Program (G.S., V.H.), Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, Departments of Epidemiology (A.B.) and Medicine (M.O'D.), McMaster University, Hamilton, Departments of Medicine and Health Policy (M.K.K.), Management and Evaluation, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), University Health Network, Toronto, University Health Network Women's Health Program Toronto (M.K.K.), and Institute for Clinical Evaluative Sciences (M.K.K.), Toronto, Ontario, Stroke Research Unit (G.S.), Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, and Stroke Unit (M.D.H.), Departments of Clinical Neurosciences, Medicine, and Community Health Sciences, University of Calgary, Alberta, Canada.

Notes

Address correspondence and reprint requests to Dr. G. Saposnik, Director of Stroke Research Unit, St. Michael's Hospital, University of Toronto, 55 Queen St. E, Suite 9-31, Toronto, Ontario, Canada M5C 1R6 [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Workflow and Short-Term Functional Outcomes in Simultaneous Acute Code Stroke Activation and Stroke Reperfusion Therapy, NeuroSci, 5, 3, (291-300), (2024).https://doi.org/10.3390/neurosci5030023
    Crossref
  2. Evaluating Transport Strategies and Local Hospital Impact on Stroke Outcomes: A RACECAT Trial Substudy, Stroke: Vascular and Interventional Neurology, 4, 3, (2024).https://doi.org/10.1161/SVIN.123.001213
    Crossref
  3. The role of stroke care infrastructure on the effectiveness of a hub-and-spoke telestroke model in South Carolina, Journal of Stroke and Cerebrovascular Diseases, 33, 6, (107702), (2024).https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107702
    Crossref
  4. Treatments and Patient Outcomes Following Stroke Center Expansion, JAMA Network Open, 7, 11, (e2444683), (2024).https://doi.org/10.1001/jamanetworkopen.2024.44683
    Crossref
  5. Annual Endovascular Thrombectomy Case Volume and Thrombectomy-capable Hospitals of Korea in Acute Stroke Care, Journal of Preventive Medicine and Public Health, 56, 2, (145-153), (2023).https://doi.org/10.3961/jpmph.22.318
    Crossref
  6. Racial and ethnic disparities in the usage and outcomes of ischemic stroke treatment in the United States, Journal of Stroke and Cerebrovascular Diseases, 32, 12, (107393), (2023).https://doi.org/10.1016/j.jstrokecerebrovasdis.2023.107393
    Crossref
  7. Time to Transfer as a Quality Improvement Imperative: Implications of a Hub-and-Spoke Health System Model on the Timing of Emergency Procedures, The Joint Commission Journal on Quality and Patient Safety, 49, 10, (539-546), (2023).https://doi.org/10.1016/j.jcjq.2023.06.008
    Crossref
  8. Adding Years to Life and Life to Years, Curious Future Insight, (147-169), (2023).https://doi.org/10.1007/978-3-031-41781-8_11
    Crossref
  9. Variation in stroke care at the hospital level: A cross-sectional multicenter study, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.1004901
    Crossref
  10. Impact of COVID-19 on the Volume of Acute Stroke Admissions: A Nationwide Survey in Japan, Neurologia medico-chirurgica, 62, 8, (369-376), (2022).https://doi.org/10.2176/jns-nmc.2022-0099
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share